Skip to main content
Clinical Trials/NCT05088681
NCT05088681RecruitingNot Applicable

Synergic Control of Posture in Peripheral Neuropathies' Patients

University of Milano Bicocca2 sites in 1 country26 target enrollmentStarted: September 3, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
26
Locations
2
Primary Endpoint
Evaluation of balance

Study Overview

Brief Summary

This is a multicenter observational study aimed to characterize multi-muscle synergy organization in relation to postural stability in individuals with Peripheral Neuropathies (PN) compared to healthy age-matched subjects and to assess the effectiveness of a rehabilitation program driven by multi-muscle synergy organization.

Detailed Description

This is a multicenter observational study of peripheral neuropathies patients aiming at characterizing multi-muscle synergy and at assessing the effectiveness of a rehabilitation program driven by multi-muscle synergy organization.

The study can be divided in two phases:

Phase 1 will included peripheral neuropathies patients and healthy age-matched subjects.

Peripheral neuropathies patients will be assessed with:

  • Neurological assessment formalized via Total Neuropathy Score-clinical version (TNSc©)
  • Nerve conduction studies
  • Impact of PN on patients' quality of life using Short Form Health Survey 36 (SF-36)
  • Functional status using Functional Independence Measure (FIM)

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject suffering from peripheral neuropathy with a TNSc© score more than 4
  • male and female subjects who are 18 years of age or older

Exclusion Criteria

  • orthopedic or neurologic comorbidities that can influence postural control
  • A control group of healthy subjects with the same demographic features of peripheral neuropathy patients wil be also included.

Outcomes

Primary Outcomes

Evaluation of balance

Time Frame: At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

Evaluation of balance using Timed Up and Go test (TUG). It is a measure of the time taken by the patient for rising from a chair, walking three meters, turning and walking back to the chair to sit down.

Evaluation of change in Anticipatory Synergy Adjustments (ASA)

Time Frame: At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

ASAs represent changes in an index of a multi-muscle synergy stabilizing the coordinate of the center of pressure (COP). Such changes may be seen in young, healthy persons about 200-300 ms prior to the action initiation.

Evaluation of mobility

Time Frame: At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

Evaluation of mobility using Six Minute Walking Test (6MWT). The 6MWT assesses distance walked over six minutes as a sub-maximal test of endurance/aerobic capacity.

Evaluation of multi-muscle synergy organization using Synergy Index (SI)

Time Frame: At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

Multi-muscle Synergy Index (SI) are new measurements of postural stability and a proxy of multi-muscle coordination. Synergy has been defined as a neural organization of a large set of effectors (e.g., muscles) providing stability of salient performance variables (e.g., center of pressure, COP). Within this framework, SI has been introduced, reflecting the relative amount of inter-trial variance that does not affect a performance variable.

Secondary Outcomes

  • Evaluation of change in electromyography (EMG) parameters(At baseline, after the 20th session of the rehabilitation program, follow up at 3 months)
  • Impact of PN on patients' quality of life(At baseline, after the 20th session of the rehabilitation program, follow up at 3 months)
  • Severity of chemotherapy induced-peripheral neuropathy(At baseline, after the 20th session of the rehabilitation program, follow up at 3 months)
  • Evaluation of change in level of disability(At baseline, after the 20th session of the rehabilitation program, follow up at 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials